We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NUVB market cap is 942.39M. The company's latest EPS is USD -0.2252 and P/E is -12.66.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 1.44M |
| Operating Income | -26.13M | -26.34M | -20.83M | -20.2M | -470.39M |
| Net Income | -20.64M | -19.65M | -13.79M | -14.79M | -462.49M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -3.06M | -93.32M | -119.73M | -99.82M |
| Net Income | -3.05M | -86.85M | -104.2M | -75.8M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 641.41M | 630.87M | 621.48M | 613.13M | 594.8M |
| Total Liabilities | 16.78M | 19.28M | 16.36M | 19.08M | 62.67M |
| Total Equity | 624.63M | 611.59M | 605.12M | 594.04M | 257.19M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 145M | 776.15M | 672.14M | 621.48M |
| Total Liabilities | 2.8M | 30.15M | 17.07M | 16.36M |
| Total Equity | 5M | 746M | 655.08M | 605.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -36.82M | -52.97M | -68M | -15.7M | -53.03M |
| Investing | -14.65M | -24.24M | 8.92M | 7.54M | 41.82M |
| Financing | 431k | 508k | 628k | 21k | 2.77M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -701k | -68.19M | -96.11M | -68M |
| Investing | -143.75M | -454.67M | 63.46M | 8.92M |
| Financing | 145.36M | 625.53M | 1.33M | 628k |
| Market Cap | 942.39M |
| Price to Earnings Ratio | -12.66 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 22.49 |
| Price to Book Ratio | 1.59 |
| Dividend Yield | - |
| Shares Outstanding | 336.57M |
| Average Volume (1 week) | 2.15M |
| Average Volume (1 Month) | 2.73M |
| 52 Week Change | 108.96% |
| 52 Week High | 4.1598 |
| 52 Week Low | 1.27 |
| Spread (Intraday) | 0.16 (5.48%) |
| Company Name | Panacea Acquisition Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ecor1cap.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
